SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 24.44-1.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1584)8/7/1999 12:54:00 PM
From: Henry Niman   of 1722
 
Monday's Barron's has an article that focuses on Pharmas buying out Biotechs. Stuart T. Weisbrod, portfolio manager of Merlin BioMed is interviewed. He thinks that most Pharmas are near the end of a new product cycle and cites JNJ and AHP as exceptions. The fund is shorting PFE. Many Biotechs are mentioned, including ENMD, MEDI, BCHE, GENZ, BRCX, CVTX, GILD, LIPO. An abstract of the article is linked to the Barron's Synopsi table at pharmacognizance.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext